AxCellerate is a partner in INNo-CHIP, an Interreg Italy–Switzerland project bringing together research and industry to advance Organ-on-Chip technologies, biomedical innovation and cross-border knowledge transfer.
Partners and ecosystem
AxCellerate emerged from the EUROSTARS NEUROCHIP project, a European research initiative focused on developing an advanced Brain-on-Chip model for neurological drug development.
This origin reflects the collaborative nature of our work: combining scientific research, precision engineering and life science expertise to create a platform designed for the needs of preclinical neuroscience.
The company builds on the combined expertise of FEMTOPRINT SA, a Swiss high-tech company specialized in precision glass microfabrication, and NMI Natural and Medical Sciences Institute, a German research institute with strong experience in micro-electrodes arrays (MEA) and innovative vitro assays for life sciences.
Our ecosystem
AxCellerate operates within an ecosystem of research, technology and industry partners that contributes to the development and application of advanced preclinical models.
This ecosystem supports our ability to connect Brain-on-Chip innovation with real research needs, helping pharma, biotech, CROs and research institutions access more predictive and human-relevant experimental systems.
AxCellerate is open to collaborations with organizations working to improve the quality and translational value of preclinical research.
We collaborate with partners interested in neuroscience drug development, disease modelling, neurotoxicity assessment, target validation and advanced in vitro testing.
Whether you are a pharmaceutical or a biotech company, CRO, research institution or technology partner, AxCellerate offers a collaborative approach designed to transform scientific questions into structured preclinical research projects.